This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Nov-Dec;80(6):546-56.

Immunotoxin therapy of hematological malignancies

L Pasqualucci¹, L Flenghi, A Terenzi, A Bolognesi, F Stirpe, B Bigerna, B Falini

Affiliations

PMID: 8647523

Review

Immunotoxin therapy of hematological malignancies

L Pasqualucci et al. Haematologica. 1995 Nov-Dec.

. 1995 Nov-Dec;80(6):546-56.

Authors

L Pasqualucci¹, L Flenghi, A Terenzi, A Bolognesi, F Stirpe, B Bigerna, B Falini

Affiliation

¹ Institute of Hematology, University of Perugia, Italy.

PMID: 8647523

No abstract available

PubMed Disclaimer

Similar articles

[Immunotoxin: from the idea of "magic bullets" to clinical applications].
Engert A, Thorpe P. Engert A, et al. Med Klin (Munich). 1990 Sep 15;85(9):555-60. Med Klin (Munich). 1990. PMID: 2233614 Review. German. No abstract available.
Advances in immunotoxin biology and therapy: a summary of the Fourth International Symposium on Immunotoxins.
Frankel AE, FitzGerald D, Siegall C, Press OW. Frankel AE, et al. Cancer Res. 1996 Feb 15;56(4):926-32. Cancer Res. 1996. PMID: 8631036 No abstract available.
[Recombinant immunotoxin for cancer therapy: current status and prospective].
Nagata S. Nagata S. Tanpakushitsu Kakusan Koso. 2001 Mar;46(4 Suppl):540-6. Tanpakushitsu Kakusan Koso. 2001. PMID: 11268658 Review. Japanese. No abstract available.
Immunotoxins and cancer therapy.
Li Z, Yu T, Zhao P, Ma J. Li Z, et al. Cell Mol Immunol. 2005 Apr;2(2):106-12. Cell Mol Immunol. 2005. PMID: 16191416 Review.
Immunotoxin therapy of lymphoid neoplasms.
Grossbard ML, Nadler LM. Grossbard ML, et al. Semin Hematol. 1994 Jan;31(1):88-97. Semin Hematol. 1994. PMID: 8122137 Review. No abstract available.

See all similar articles

Cited by

Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components.
Dosio F, Brusa P, Cattel L. Dosio F, et al. Toxins (Basel). 2011 Jul;3(7):848-83. doi: 10.3390/toxins3070848. Epub 2011 Jul 14. Toxins (Basel). 2011. PMID: 22069744 Free PMC article. Review.
Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview.
Polito L, Djemil A, Bortolotti M. Polito L, et al. Biomedicines. 2016 Jun 1;4(2):12. doi: 10.3390/biomedicines4020012. Biomedicines. 2016. PMID: 28536379 Free PMC article. Review.
Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience.
Flavell DJ, Flavell SU. Flavell DJ, et al. Toxins (Basel). 2022 Aug 18;14(8):563. doi: 10.3390/toxins14080563. Toxins (Basel). 2022. PMID: 36006226 Free PMC article. Review.
An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Klimka A, Barth S, Matthey B, Roovers RC, Lemke H, Hansen H, Arends JW, Diehl V, Hoogenboom HR, Engert A. Klimka A, et al. Br J Cancer. 1999 Jun;80(8):1214-22. doi: 10.1038/sj.bjc.6690488. Br J Cancer. 1999. PMID: 10376974 Free PMC article.
Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.
Polito L, Bortolotti M, Pedrazzi M, Bolognesi A. Polito L, et al. Toxins (Basel). 2011 Jun;3(6):697-720. doi: 10.3390/toxins3060697. Epub 2011 Jun 22. Toxins (Basel). 2011. PMID: 22069735 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information